amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule [Talicia]
RxNorm concept 2262032, branded drug (sbd). Prescribable name: TALICIA 250 MG / 10 MG / 12.5 MG Delayed Release Oral Capsule.
- RxCUI
- 2262032
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2262032 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Talicia 250 MG / 10 MG / 12.5 MG Delayed Release Oral Capsule
Related concepts
- amoxicillin 250 MG (SCDC, consists of)
- omeprazole 10 MG (SCDC, consists of)
- rifabutin 12.5 MG (SCDC, consists of)
- amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG [Talicia] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Talicia (BN, has ingredient)
- amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2262032 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2262032 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2262032. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.